Read More 2 minute read Cannabis Markets Movers Cannabis Stock Gainers And Losers From February 1, 2022 By Benzinga Insights Today, 3:04 AM GAINERS: MedMen Enterprises (OTC:MMNFF) shares closed up 58.51% at $0.16 ACB
Read More 2 minute read Cannabis Markets Movers Cannabis Stock Gainers And Losers From January 31, 2022 By Benzinga Insights Today, 3:04 AM GAINERS: Greenlane Hldgs (NASDAQ:GNLN) shares closed up 18.20% at $0.76 ACB
Read More 2 minute read Cannabis Markets Movers Cannabis Stock Gainers And Losers From January 26, 2022 By Benzinga Insights Today, 3:04 AM GAINERS: Item 9 Labs (OTC:INLB) shares closed up 10.54% at $1.05 ACB
Read More 2 minute read Cannabis Markets Movers Cannabis Stock Gainers And Losers From January 18, 2022 By Benzinga Insights Today, 3:04 AM GAINERS: Item 9 Labs (OTC:INLB) shares closed up 11.46% at $1.07 ACB
Read More 1 minute read Cannabis Markets Movers Cannabis Stock Gainers And Losers From January 12, 2022 By Benzinga Insights Today, 3:04 AM GAINERS: Cannabix Technologies (OTC:BLOZF) shares closed up 8.23% at $0.56 BLOZF
Read More 1 minute read Cannabis Markets Movers Cannabis Stock Gainers And Losers From January 7, 2022 By Benzinga Insights Today, 3:04 AM GAINERS: Cannabix Technologies (OTC:BLOZF) shares closed up 10.07% at $0.45 BLOZF
Read More 32 minute read Intraday Update Markets Movers News Options Trading Ideas Stocks That Hit 52-Week Lows On Thursday By Benzinga Insights Today, 3:04 AM On Thursday, 615 stocks hit new 52-week lows. AAOI
Read More 2 minute read Cannabis Markets Movers Cannabis Stock Gainers And Losers From January 5, 2022 By Benzinga Insights Today, 3:04 AM GAINERS: Rhinomed (OTC:RHNMF) shares closed up 8.04% at $0.21 ACB
Read More 1 minute read Cannabis Markets Movers Cannabis Stock Gainers And Losers From January 3, 2022 By Benzinga Insights Today, 3:04 AM GAINERS: BioHarvest Sciences (OTC:CNVCF) shares closed up 22.22% at $0.44 ACB
Read More 2 minute read Biotech FDA General News Penny Stocks Small Cap The Week Ahead In Biotech (Dec.26-Jan. 1): Xeris FDA Decision, Pending Clinical Readouts In Focus In Final Week Of Year By Shanthi Rexaline Today, 3:04 AM Biopharma stocks eked out modest gains in the week ending Dec. 23, with regulatory decisions, clinical readouts and COVID-19 treatment and vaccine developments dictating sentiment. ADAG